| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/25/2004 | WO2002092756A8 Insulin producing cells derived from human embryonic stem cells |
| 03/25/2004 | WO2002086050A3 Ion channel polynucleotide arrays comprising non-conserved regions identifying ion channel family member expression profiles |
| 03/25/2004 | WO2002085093A3 Replikin peptides and uses thereof |
| 03/25/2004 | WO2002083859A8 Surface proteins of streptococcus pyogenes |
| 03/25/2004 | WO2002079492A8 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| 03/25/2004 | WO2002076205A3 Compositions and methods of zearalenone detoxification |
| 03/25/2004 | WO2002074048A3 P-glycoproteins and uses thereof |
| 03/25/2004 | WO2002072832A3 Therapeutic binding molecules |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002059357A3 Assay and kit for analyzing gene expression |
| 03/25/2004 | WO2002059321A3 Hepatitis c virus replicons and replicon enhanced cells |
| 03/25/2004 | WO2002055557A3 Human proteins and nucleic acids encoding same |
| 03/25/2004 | WO2002046434A3 Plasmid vectors |
| 03/25/2004 | WO2002044342A3 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 03/25/2004 | WO2002034288A8 Vaccine for treating allergy |
| 03/25/2004 | WO2002017899A3 Regulation of angiogenesis via modulation of edg receptor mediated signal transduction comprising sphingosine-1-phosphate administration |
| 03/25/2004 | WO2002014550A9 Transcription factor target gene discovery |
| 03/25/2004 | WO2001092470A3 Dna expression vectors and methods of use |
| 03/25/2004 | US20040060087 Chimeric progeny of nicotiana excelsior and nicotiana benthamiana for generation of enhanced properties and biomass; bioreactor for expression of heterologous proteins |
| 03/25/2004 | US20040060086 Interspecific nicotiana hybrids and their progeny |
| 03/25/2004 | US20040060084 Regulatory nucleotide sequences for controlling anther specific expression of heterologus genes and proteins |
| 03/25/2004 | US20040060083 Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content |
| 03/25/2004 | US20040060082 Generating soybean plants with single locus dominant alleles for propagating plants with enhanced oil production and improved agronomic characteristics |
| 03/25/2004 | US20040060081 Plant genes that confer resistance to strains of magnaporthe grisea having avri co39 cultivar specificity gene |
| 03/25/2004 | US20040060080 Gibberellin 2-oxidase gene, functions and uses thereof |
| 03/25/2004 | US20040060079 Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome P450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene |
| 03/25/2004 | US20040060078 Propagating transgenic arabidopsis and microtomato comprising vegetative, male reproductive and glyphosate resistance |
| 03/25/2004 | US20040059530 Method for analyzing mass spectra |
| 03/25/2004 | US20040059242 Body composition measurement method and apparatus |
| 03/25/2004 | US20040059098 Egf motif protein, egfl6 materials and methods |
| 03/25/2004 | US20040059093 Methods to construct multimeric DNA and polymeric protein sequences as direct fusions or with linkers |
| 03/25/2004 | US20040059091 Protein complexes and process for producing the same |
| 03/25/2004 | US20040059090 Novel compounds |
| 03/25/2004 | US20040059089 Comprises receptor protein for controlling gene expression in transgenic cells; for diagnosis, prevention and treatment of heart, tumor and urogenital disorders |
| 03/25/2004 | US20040059087 Peptide nucleic acids |
| 03/25/2004 | US20040058886 Short interfering RNAs having a hairpin structure containing a non-nucleotide loop |
| 03/25/2004 | US20040058884 Detecting diseases by Selex method; anticancer agents |
| 03/25/2004 | US20040058883 Oligonucleotide compositions and their use for the modulation of immune responses |
| 03/25/2004 | US20040058870 Reduce blood glucose concentration; antidiabetic agent; respiratory system disorders |
| 03/25/2004 | US20040058869 Methods and reagents for modulating cholesterol levels |
| 03/25/2004 | US20040058860 Novel bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 03/25/2004 | US20040058448 Transgenic gram negative bacteria for production of oligo and/or polysaccharides; gene therapy and vaccine development |
| 03/25/2004 | US20040058447 Gene transfer methods |
| 03/25/2004 | US20040058446 Transfecting cells with nucleic acids; gene therapy |
| 03/25/2004 | US20040058443 Manipulation of non-terminally differentiated cells using the Notch pathway |
| 03/25/2004 | US20040058441 Using bird stem cell to propagate transgenic tissues which generate therapeutic vaccine for treatment of cancer; immunotherapy |
| 03/25/2004 | US20040058429 Recombinant saccharomyces cerevisiae expressing chimeric glucose transporters |
| 03/25/2004 | US20040058427 Herbicide resistant plants |
| 03/25/2004 | US20040058424 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058419 Thermostable L-arabinose isomerase and process for preparing D-tagatose |
| 03/25/2004 | US20040058417 Covalent joining of DNA to RNA by vaccinia topoisomerase and uses thereof |
| 03/25/2004 | US20040058415 Preparing modified/artificial polypeptides; mimetics |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040058410 Fermentative carotenoid production |
| 03/25/2004 | US20040058406 Assay methods and systems |
| 03/25/2004 | US20040058403 Using high speed fluorescence activated cell sorting (FACS) to isolate bacterial cells expressing ligand binding polypeptides |
| 03/25/2004 | US20040058402 Method for purifying the helicobacter adhesin-like protein a (alpa) |
| 03/25/2004 | US20040058400 Multivalent and multispecific binding proteins, their manufacture and use |
| 03/25/2004 | US20040058398 Pancreatic progenitor cells and methods for isolating the same |
| 03/25/2004 | US20040058394 Humanized anti-LT-beta-R antibodies |
| 03/25/2004 | US20040058379 Tumor suppressor gene, p47Ing3 |
| 03/25/2004 | US20040058374 Method for mixing nucleic acid with a water insoluble medium and appalication thereof |
| 03/25/2004 | US20040058371 Novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 03/25/2004 | US20040058370 Extracting and recovering RNA sequences via absorption and desorption to macromolecular solid support |
| 03/25/2004 | US20040058369 Comprises nucleotide sequences coding heliothis ecdysone receptor for controlling gene transcrption in transgenic animal models |
| 03/25/2004 | US20040058366 Comprises DNA coding brain-muscle-arnt-like protein 2 (BMAL2) for diagnosis and treatment of circadian rythm disorders |
| 03/25/2004 | US20040058365 Molecules for disease detection and treatment |
| 03/25/2004 | US20040058362 Polymerase chimeras |
| 03/25/2004 | US20040058361 Antibacterial treatments |
| 03/25/2004 | US20040058360 Selecting, accumulating, precipitating and recovering small copy number nucleotide sequences; nucleic acid precipation |
| 03/25/2004 | US20040058358 Lipid metabolism transcription factor |
| 03/25/2004 | US20040058353 Comprises nucleotide sequences coding transport proteins for diagnosis and treatment of pain, psychotic, eating and nervous system disorders |
| 03/25/2004 | US20040058350 Regulation of human secretin receptor-like gpcr |
| 03/25/2004 | US20040058348 Mesophilic bacterial heat resistant regulatory sequences for use as transfer tool in genetic engineering |
| 03/25/2004 | US20040058346 Polynucleotide cleavage agent switched on by photo irradiation |
| 03/25/2004 | US20040058344 Transgenic cells comprising precursor messenger RNA for diagnosis of infectious, cell proliferative, nervous system and metabolic disorders |
| 03/25/2004 | US20040058342 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 03/25/2004 | US20040058338 Novel proteins and nucleic acids encoding same |
| 03/25/2004 | US20040058337 Process for determining the tumorcidal potential of a sample the use of a nucleic acid which is downregulated in human tumor cells |
| 03/25/2004 | US20040058334 Using microsatelite sequences and homologous genetic exchange diagnose fibrodysplasia ossificans progressiva |
| 03/25/2004 | US20040058331 Blood testing method, testing chip, and testing device |
| 03/25/2004 | US20040058330 Using thermophilic synthetases to prepare and replicate preferential nucleotide sequences; primer, probe and complimentary DNA biosynthesis |
| 03/25/2004 | US20040058326 Identification and use of molecules implicated in pain |
| 03/25/2004 | US20040058324 Gene sp17 inhibiting lesion formation in plant and utilization thereof |
| 03/25/2004 | US20040058322 Conjugates between a minor groove binding the trimer of 1,2-dihydro- (3H)-pyrrolo(3,3-e)indole-7-carboxylate and an oligonucleotide and forms stable hybrids with complementary target sequence |
| 03/25/2004 | US20040058321 Comprises nucleotide sequences coding transforming growth factor binding proteins for diagnosis and treatment of osteoporosis and osteopenia |
| 03/25/2004 | US20040058319 Comprises nucleotide sequences coding urogenital polypeptide for diagnosis and treatment cancer |
| 03/25/2004 | US20040058318 Transcripton factor comprising tyrosine kinase and interferon binding domains for diagnosis and treatment of autoimmune and immune response disorders; imunosuppressants |
| 03/25/2004 | US20040058317 Using high throughput assay to detect restriction fragment length polymorphisms in gene coding mannose binding protein |
| 03/25/2004 | US20040058316 Use of recombinant antigens to determine the immune status of an animal |
| 03/25/2004 | US20040057969 Compositions containing stabilized hepatitis antigen and methods of their use |
| 03/25/2004 | US20040057960 Activating hepatitis C virus (HCV)-specific T cells, including CD4+ and CD8+ T cells, using fusion proteins comprising HCV, NS3, NS4, NS5a, and NS5b polypeptides, polynucleotides encoding such fusion proteins; immunogens |
| 03/25/2004 | US20040057959 Recombitope peptides |
| 03/25/2004 | US20040057953 Modified peptides as therapeutic agents |
| 03/25/2004 | US20040057933 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 03/25/2004 | US20040057932 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 03/25/2004 | US20040057931 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 03/25/2004 | US20040057928 Use of IL-6R/IL-6 chimera, a mutein, isoform, fused protein, functional derivative, active fraction or circularly permutated derivative or a salt thereof, for manufacture of medicament for therapy and/or prophylaxis |
| 03/25/2004 | US20040057925 Methods of enhancing bioactivity of chemokines |
| 03/25/2004 | US20040057902 For use in diagnosis and therapy |